시장보고서
상품코드
2050611

골생검 시장 : 시술 유형별, 용도별, 제품 유형별, 가이드 기술별, 최종사용자별, 지역별

Bone Biopsy Market, By Procedure Type, By Application, By Product Type, By Guidance Technology, By End User, By Geography

발행일: | 리서치사: 구분자 Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 4,500 금액 안내 화살표 ₩ 6,953,000
PDF & Excel (Multi User License - Up to 7 Users) help
PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 7,000 금액 안내 화살표 ₩ 10,817,000
PDF & Excel (Corporate User License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 금액 안내 화살표 ₩ 15,453,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

골생검 시장은 2026년에 8억 2,210만 달러로 추정되고 있으며, 2033년까지 12억 6,910만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 6.4%로 성장할 것으로 전망되고 있습니다.

리포트 범위 리포트 상세
기준연도 : 2025년 2026년 시장 규모 : 8억 2,210만 달러
과거 데이터 기간 : 2020-2024년 예측 기간 : 2026-2033년
2026-2033년 예측 기간의 CAGR : 6.40% 2033년 시장 규모 예측 : 12억 6,910만 달러

세계의 뼈 생검 시장은 진단 목적으로 뼈 조직 샘플을 채취하고 분석하기 위해 고안된 전문 기술을 포괄하는 의료 진단 산업의 중요한 부문입니다. 뼈 생검은 원발성 골암, 전이성 종양, 감염성 질환, 대사성 골질환 등 다양한 뼈 관련 질환의 진단에 필수적인 의료적 개입입니다. 이 시술은 최소 침습적 기술을 사용하여 소량의 뼈 조직 샘플을 채취하여 병리학자나 종양 전문의가 종합적인 조직 병리학적 검사를 수행할 수 있도록 합니다. 이 시장에는 바늘 생검, 개방형 생검, 영상 유도 생검 등 특정 임상 요건과 환자 상태에 맞게 설계된 다양한 생검 방법이 포함됩니다. CT 유도하 생검, MRI 유도하 생검과 같은 첨단 영상 기술은 뼈 생검의 정확성과 안전성에 혁명을 일으켜 환자의 불편함을 줄이면서 진단의 정확성을 향상시키고 있습니다. 전 세계에서 골암, 골다공증 및 기타 골격계 질환의 유병률이 증가함에 따라 신뢰할 수 있는 뼈 생검 기술에 대한 수요가 크게 증가하고 있습니다. 의료진은 최적의 조직 채취와 좋은 치료 결과를 보장하기 위해 특수 바늘, 트레핀, 자동 생검 시스템 등 첨단 생검 장비에 대한 의존도를 높이고 있습니다. 첨단 기술과 최소침습적 접근법의 융합은 이 전문 의료 시장 부문에서 혁신을 주도하고 있습니다.

시장 역학:

세계의 뼈 생검 시장은 효과적인 치료 계획을 수립하기 위해 정확한 진단 절차가 필요하고, 전 세계에서 골암 및 전이성 질환의 발생률이 증가하는 등 몇 가지 주요 시장 촉진요인에 의해 주도되고 있습니다. 노인은 생검이 필요한 뼈 관련 질환에 걸릴 위험이 높기 때문에 전 세계에서 고령화가 시장 성장에 크게 기여하고 있습니다. 실시간 CT 및 MRI 유도 생검 시스템을 포함한 영상 유도 생검 기술의 발전은 시술의 정확성을 높이면서 환자의 불편함을 최소화하여 시장 보급을 촉진하고 있습니다. 신흥 국가의 의료비 증가와 의료 인프라 개선은 뼈 생검 시장 확대를 위한 큰 성장 기회를 창출하고 있습니다. 그러나 시장에는 눈에 띄는 제약도 존재합니다. 예를 들어 고급 생검 장비 및 영상 진단 시스템에 따른 높은 비용은 자원이 한정된 의료 환경에서 접근성을 제한하는 요인이 될 수 있습니다. 또한 출혈, 감염, 골절 위험과 같은 뼈 생검 시술에 따른 잠재적 합병증으로 인해 일부 환자나 의료진이 이 진단법을 선택하는 것을 주저할 수 있습니다. 또한 첨단 영상 진단법 및 액체생검을 포함한 대체 진단기술의 보급은 기존의 뼈 생검술에 대한 경쟁적 도전이 되고 있습니다. 이러한 제약에도 불구하고 시술의 복잡성을 줄이고 환자의 예후를 개선하는 혁신적인 최소침습 생검 기술 및 자동화 시스템 개발을 통해 큰 기회가 창출되고 있습니다. 맞춤의료와 정밀 종양학에 대한 관심이 높아지면서 뼈 조직 샘플에 대한 포괄적인 분자 및 유전자 분석을 제공하고 표적 치료 접근을 가능하게 하는 전문 뼈 생검 기술에 더 많은 기회가 생기고 있습니다.

본 조사의 주요 특징:

  • 이 보고서는 각 부문의 잠재적 매출 기회를 밝히고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
  • 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
  • 이 보고서는 회사 개요, 제품 포트폴리오, 주요 특징, 재무 성과 및 전략과 같은 매개 변수를 기반으로 세계의 뼈 생검 시장의 주요 기업 개요을 작성합니다.
  • 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
  • 이 세계의 뼈 생검 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
  • 이해관계자들은 글로벌 뼈 생검 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.

목차

제1장 조사 목적과 전제조건

제2장 시장 전망

제3장 시장 역학·규제·동향 분석

제4장 세계의 골생검 시장 : 시술 유형별, 2021-2033년

제5장 세계의 골생검 시장 : 용도별, 2021-2033년

제6장 세계의 골생검 시장 : 제품 유형별, 2021-2033년

제7장 세계의 골생검 시장 : 가이던스 기술별, 2021-2033년

제8장 세계의 골생검 시장 : 최종사용자별, 2021-2033년

제9장 세계의 골생검 시장 : 지역별, 2021-2033년

제10장 경쟁 구도

제11장 애널리스트의 제안

제12장 참고 문헌 및 조사 방법

KSA 26.06.10

Bone Biopsy Market is estimated to be valued at USD 822.1 Mn in 2026 and is expected to reach USD 1,269.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.4% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 822.1 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.40% 2033 Value Projection: USD 1,269.1 Mn

The global bone biopsy market represents a critical segment within the medical diagnostics industry, encompassing specialized procedures designed to extract and analyze bone tissue samples for diagnostic purposes. Bone biopsy procedures are essential medical interventions utilized to diagnose various bone-related conditions, including primary bone cancers, metastatic tumors, infections, and metabolic bone diseases. These procedures involve the extraction of small bone tissue samples through minimally invasive techniques, enabling pathologists and oncologists to conduct comprehensive histopathological examinations. The market encompasses various biopsy methods, including needle biopsy, open biopsy, and image-guided biopsy procedures, each tailored to specific clinical requirements and patient conditions. Advanced imaging technologies such as CT-guided and MRI-guided biopsies have revolutionized the precision and safety of bone biopsy procedures, reducing patient discomfort while enhancing diagnostic accuracy. The growing prevalence of bone cancers, osteoporosis, and other skeletal disorders globally has significantly increased the demand for reliable bone biopsy procedures. Healthcare providers increasingly rely on sophisticated biopsy instruments, including specialized needles, trephines, and automated biopsy systems, to ensure optimal tissue sampling and patient outcomes. The integration of advanced technologies and minimally invasive approaches continues to drive innovation within this specialized medical market segment.

Market Dynamics:

The global bone biopsy market is propelled by several key drivers, including the escalating incidence of bone cancers and metastatic diseases worldwide, which necessitates accurate diagnostic procedures for effective treatment planning. The aging global population contributes significantly to market growth, as elderly individuals face higher risks of developing bone-related disorders requiring biopsy interventions. Technological advancements in imaging-guided biopsy techniques, including real-time CT and MRI guidance systems, enhance procedural accuracy while minimizing patient discomfort, thereby driving market adoption. Increasing healthcare expenditure and improved healthcare infrastructure in developing economies create substantial growth opportunities for bone biopsy market expansion. However, the market faces notable restraints, including the high costs associated with advanced biopsy equipment and imaging systems, which can limit accessibility in resource-constrained healthcare settings. Potential complications associated with bone biopsy procedures, such as bleeding, infection, and fracture risks, may deter some patients and healthcare providers from opting for these diagnostic methods. Additionally, the availability of alternative diagnostic techniques, including advanced imaging modalities and liquid biopsies, poses competitive challenges to traditional bone biopsy procedures. Despite these constraints, significant opportunities emerge through the development of innovative, minimally invasive biopsy technologies and automated systems that reduce procedural complexity and improve patient outcomes. The growing emphasis on personalized medicine and precision oncology creates additional opportunities for specialized bone biopsy techniques that can provide comprehensive molecular and genetic analysis of bone tissue samples, enabling targeted therapeutic approaches.

Key Features of the Study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global bone biopsy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include BD (Becton, Dickinson and Company), Medtronic, Abbott Laboratories, Stryker Corporation, Olympus Corporation, Hologic, Inc., Thermo Fisher Scientific, Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Boston Scientific Corporation, Merit Medical Systems, Fujifilm Holdings Corporation, and Karl Storz GmbH & Co. KG.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global bone biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bone biopsy market

Market Segmentation

  • Procedure Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Closed (Percutaneous) Biopsy
  • Open Biopsy
  • Application Insights (Revenue, USD Mn, 2021 - 2033)
  • Cancer Diagnosis
    • Primary Bone Tumors
    • Metastatic Bone Disease
  • Bone Infection Diagnosis
    • Osteomyelitis
    • Septic Arthritis-related Bone Infections
  • Metabolic Bone Disorders
    • Osteoporosis (Diagnostic Confirmation)
    • Paget Disease of Bone
    • Renal Osteodystrophy
  • Genetic Disorders
  • Others (Bone Trauma Assessment, etc.)
  • Product Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Needle Biopsy
    • Fine Needle Aspiration Biopsy (FNAB)
    • Core Needle Biopsy
  • Bone Biopsy Kits
    • Pre-packaged Kits
    • Customized Kits
  • Biopsy Guns
    • Semi-automatic biopsy guns
    • Fully automatic biopsy guns
  • Surgical Biopsy
    • Excisional Biopsy
    • Incisional Biopsy
  • Other Instruments & Accessories
  • Guidance Technology Insights (Revenue, USD Mn, 2021 - 2033)
  • Ultrasound-Guided Biopsy
  • CT-Guided Biopsy
    • Conventional CT
    • Cone-beam CT
  • MRI-Guided Biopsy
  • Fluoroscopy or X-ray Guided Biopsy
  • End User Insights (Revenue, USD Mn, 2021 - 2033)
  • Hospitals
  • Diagnostic Laboratories
  • Specialty Clinics
  • Ambulatory surgical centers
  • Others (Academic & Research Institutes, etc.)
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • BD (Becton, Dickinson and Company)
  • Medtronic
  • Abbott Laboratories
  • Stryker Corporation
  • Olympus Corporation
  • Hologic, Inc.
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • GE Healthcare
  • Philips Healthcare
  • Canon Medical Systems
  • Boston Scientific Corporation
  • Merit Medical Systems
  • Fujifilm Holdings Corporation
  • Karl Storz GmbH & Co. KG

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Bone Biopsy Market, By Procedure Type
    • Global Bone Biopsy Market, By Application
    • Global Bone Biopsy Market, By Product Type
    • Global Bone Biopsy Market, By Guidance Technology
    • Global Bone Biopsy Market, By End User
    • Global Bone Biopsy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Bone Biopsy Market, By Procedure Type, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Closed (Percutaneous) Biopsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Open Biopsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

5. Global Bone Biopsy Market, By Application, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Cancer Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
      • Primary Bone Tumors
      • Metastatic Bone Disease
  • Bone Infection Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
      • Osteomyelitis
      • Septic Arthritis-related Bone Infections
  • Metabolic Bone Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
      • Osteoporosis (Diagnostic Confirmation)
      • Paget Disease of Bone
      • Renal Osteodystrophy
  • Genetic Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Others (Bone Trauma Assessment, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

6. Global Bone Biopsy Market, By Product Type, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Needle Biopsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
      • Fine Needle Aspiration Biopsy (FNAB)
      • Core Needle Biopsy
  • Bone Biopsy Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
      • Pre-packaged Kits
      • Customized Kits
  • Biopsy Guns
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
      • Semi-automatic biopsy guns
      • Fully automatic biopsy guns
  • Surgical Biopsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
      • Excisional Biopsy
      • Incisional Biopsy
  • Other Instruments & Accessories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

7. Global Bone Biopsy Market, By Guidance Technology, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Ultrasound-Guided Biopsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • CT-Guided Biopsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
      • Conventional CT
      • Cone-beam CT
  • MRI-Guided Biopsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Fluoroscopy or X-ray Guided Biopsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

8. Global Bone Biopsy Market, By End User, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Ambulatory surgical centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Others (Academic & Research Institutes, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

9. Global Bone Biopsy Market, By Region, 2021 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Procedure Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Guidance Technology, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Procedure Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Guidance Technology, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Procedure Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Guidance Technology, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Procedure Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Guidance Technology, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Procedure Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Guidance Technology, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Procedure Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Guidance Technology, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • BD (Becton, Dickinson and Company)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stryker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Olympus Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hologic, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Philips Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Canon Medical Systems
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merit Medical Systems
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fujifilm Holdings Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Karl Storz GmbH & Co. KG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
문의하기